Maynard Um
-
-
-
-
-
-
-
ProKidney Corp. (PROK) PT Raised to $8 at UBS
-
-
-
-
-
-
-
ProKidney reports positive phase 2 trial results for kidney disease therapy
-
-
-
-
-
-
-
Guggenheim Starts ProKidney Corp. (PROK) at Buy
-
-
-
-
-
-
-
ProKidney Corp (PROK) Announces Proposed $125 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering
-
-
405,069 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

